Nuo Therapeutics, Inc. Receivables Turnover Ratio (CMXI), from the second quarter 2026 to the second quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nuo Therapeutics, Inc.  (CMXI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Nuo Therapeutics Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Nuo Therapeutics, Inc.'s ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 6.06, above the company average. This is a clear sign of healthy business climate in the Medical Laboratories industry and improving liquidity at their respective customers, during the second quarter 2026. Nuo Therapeutics's Accounts Receivable average collection period in the Jun 30 2026 quarter,